Market Overview:
The global leukemia therapeutic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of leukemia, rising awareness about leukemia and its treatment options, and the launch of novel therapies. The global leukemia therapeutic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into induction therapy, consolidation therapy, and maintenance therapy. Induction therapy dominates this market owing to its high adoption rate for newly diagnosed patients with leukemia. By application, cancer research centers account for a major share in this market owing to their large patient population base and increasing focus on R&D activities for new therapies for leukemia patients.
Product Definition:
Leukemia Therapeutic is a drug used to treat leukemia, a type of cancer that affects the blood and bone marrow. Leukemia Therapeutic helps stop the growth of leukemia cells and may help improve symptoms.
Induction Therapy:
Induction therapy is a new treatment method for leukemia and lymphoma. It’s majorly used in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL). According to the American Society of Clinical Oncology, more than 60% of cases of ALL are treated with chemotherapy drugs. The rest 40% require some other form of induction therapy such as prokinetic agents, immunomodulators or biologic response modifiers.
Consolidation Therapy:
Consolidation therapy is a treatment approach that aims at reducing the exposure of patients to cytotoxic drugs. It involves the use of two or more drugs, which are usually synergistic in nature and are used in combination to achieve higher levels of activity than would be possible with either drug alone. The purpose is to reduce toxic side effects while maintaining an effective therapeutic level for achieving remission.
Application Insights:
The cancer research centers segment dominated the global leukemia therapeutic market in 2017. This can be attributed to the presence of a strong pipeline and presence of prominent manufacturers such as Novartis, Pfizer, and sanofi-aventis in North America. Moreover, this application segment is expected to grow at a lucrative rate over the forecast period owing to increasing R&D activities pertaining to leukemia treatment drugs.
Diagnostic laboratories are anticipated to exhibit significant growth over the forecast period due largely on an increase in prevalence of chronic diseases such as cancer that require regular blood tests for diagnosis or monitoring purposes. Furthermore, an increase in demand for point-of-care diagnostic tests is also likely drive growth during this period owing largely on technological advancements coupled with rise in awareness regarding early detection of diseases among consumers globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable government policies and funding programs, and increasing healthcare expenditure are some factors contributing to its growth. In addition, the availability of effective treatment methods is expected to drive regional market over the forecast period. Asia Pacific is estimated to be fastest-growing region during the forecast period owing to rising incidences of leukemia coupled with growing awareness about available treatment options in emerging countries such as China & India.
Major companies include but are not limited to: AbbVie Inc.; Celgene Corp.; Pfizer Inc.; Biogen Inc.; Novartis AG; Allergan PLC; FK- horma N.V.
Growth Factors:
- Increasing incidence of leukemia
- Growing awareness about leukemia and its treatment options
- Rising demand for better and more effective therapies for leukemia patients
- Technological advancements in the field of leukemia therapeutics
- Availability of government funding for research on new leukemia therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Leukemia Therapeutic Market Research Report
By Type
Induction Therapy, Consolidation Therapy, Maintenance Therapy
By Application
Cancer Research Centers, Diagnostic Laboratories, Hospitals andClinics, Others
By Companies
Genzyme, Novartis International, Pfizer, Roche Holding, Celgene Corporation, Ariad Pharmaceuticals, Clavis Pharma, Sunesis Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Leukemia Therapeutic Market Report Segments:
The global Leukemia Therapeutic market is segmented on the basis of:
Types
Induction Therapy, Consolidation Therapy, Maintenance Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Research Centers, Diagnostic Laboratories, Hospitals andClinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Genzyme
- Novartis International
- Pfizer
- Roche Holding
- Celgene Corporation
- Ariad Pharmaceuticals
- Clavis Pharma
- Sunesis Pharmaceuticals
Highlights of The Leukemia Therapeutic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Induction Therapy
- Consolidation Therapy
- Maintenance Therapy
- By Application:
- Cancer Research Centers
- Diagnostic Laboratories
- Hospitals andClinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Leukemia Therapeutic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Leukemia therapeutic is a term used to describe any treatment that helps leukemia patients live longer and healthier lives. Some common leukemia therapies include chemotherapy, radiation therapy, and stem cell transplantation.
Some of the key players operating in the leukemia therapeutic market are Genzyme, Novartis International, Pfizer, Roche Holding, Celgene Corporation, Ariad Pharmaceuticals, Clavis Pharma, Sunesis Pharmaceuticals.
The leukemia therapeutic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Leukemia Therapeutic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Leukemia Therapeutic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Leukemia Therapeutic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Leukemia Therapeutic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Leukemia Therapeutic Market Size & Forecast, 2020-2028
4.5.1 Leukemia Therapeutic Market Size and Y-o-Y Growth
4.5.2 Leukemia Therapeutic Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Induction Therapy
5.2.2 Consolidation Therapy
5.2.3 Maintenance Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer Research Centers
6.2.2 Diagnostic Laboratories
6.2.3 Hospitals andClinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Leukemia Therapeutic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Leukemia Therapeutic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Induction Therapy
9.6.2 Consolidation Therapy
9.6.3 Maintenance Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer Research Centers
9.10.2 Diagnostic Laboratories
9.10.3 Hospitals andClinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Induction Therapy
10.6.2 Consolidation Therapy
10.6.3 Maintenance Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer Research Centers
10.10.2 Diagnostic Laboratories
10.10.3 Hospitals andClinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Induction Therapy
11.6.2 Consolidation Therapy
11.6.3 Maintenance Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer Research Centers
11.10.2 Diagnostic Laboratories
11.10.3 Hospitals andClinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Induction Therapy
12.6.2 Consolidation Therapy
12.6.3 Maintenance Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer Research Centers
12.10.2 Diagnostic Laboratories
12.10.3 Hospitals andClinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Induction Therapy
13.6.2 Consolidation Therapy
13.6.3 Maintenance Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer Research Centers
13.10.2 Diagnostic Laboratories
13.10.3 Hospitals andClinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Leukemia Therapeutic Market: Competitive Dashboard
14.2 Global Leukemia Therapeutic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Genzyme
14.3.2 Novartis International
14.3.3 Pfizer
14.3.4 Roche Holding
14.3.5 Celgene Corporation
14.3.6 Ariad Pharmaceuticals
14.3.7 Clavis Pharma
14.3.8 Sunesis Pharmaceuticals
